HUE062891T2 - Kemoterápia által indukált perifériás neuropátiával összefüggõ neuropátiás fájdalom kezelése - Google Patents

Kemoterápia által indukált perifériás neuropátiával összefüggõ neuropátiás fájdalom kezelése

Info

Publication number
HUE062891T2
HUE062891T2 HUE22730040A HUE22730040A HUE062891T2 HU E062891 T2 HUE062891 T2 HU E062891T2 HU E22730040 A HUE22730040 A HU E22730040A HU E22730040 A HUE22730040 A HU E22730040A HU E062891 T2 HUE062891 T2 HU E062891T2
Authority
HU
Hungary
Prior art keywords
chemotherapy
neuropathic pain
pain associated
peripheral neuropathy
treating neuropathic
Prior art date
Application number
HUE22730040A
Other languages
English (en)
Inventor
Basil Rigas
Original Assignee
Medicon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicon Pharmaceuticals Inc filed Critical Medicon Pharmaceuticals Inc
Publication of HUE062891T2 publication Critical patent/HUE062891T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dermatology (AREA)
  • Magnetic Treatment Devices (AREA)
  • Medicinal Preparation (AREA)
HUE22730040A 2021-05-24 2022-05-23 Kemoterápia által indukált perifériás neuropátiával összefüggõ neuropátiás fájdalom kezelése HUE062891T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163192246P 2021-05-24 2021-05-24

Publications (1)

Publication Number Publication Date
HUE062891T2 true HUE062891T2 (hu) 2023-12-28

Family

ID=82019337

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE22730040A HUE062891T2 (hu) 2021-05-24 2022-05-23 Kemoterápia által indukált perifériás neuropátiával összefüggõ neuropátiás fájdalom kezelése

Country Status (21)

Country Link
US (1) US20240180936A1 (hu)
EP (2) EP4275749A3 (hu)
JP (1) JP2024520463A (hu)
KR (1) KR20240013092A (hu)
CN (1) CN117377476A (hu)
AU (1) AU2022283458A1 (hu)
BR (1) BR112023024422A2 (hu)
CA (1) CA3220195A1 (hu)
DK (1) DK4114403T3 (hu)
ES (1) ES2952672T3 (hu)
FI (1) FI4114403T3 (hu)
HR (1) HRP20230541T1 (hu)
HU (1) HUE062891T2 (hu)
LT (1) LT4114403T (hu)
MA (1) MA58889B1 (hu)
MX (1) MX2023013855A (hu)
PL (1) PL4114403T3 (hu)
PT (1) PT4114403T (hu)
RS (1) RS64471B1 (hu)
SI (1) SI4114403T1 (hu)
WO (1) WO2022251805A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024112725A1 (en) 2022-11-23 2024-05-30 Medicon Pharmaceuticals, Inc. Treating pain associated with central sensitization

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060241074A1 (en) * 2001-08-14 2006-10-26 The General Hospital Corporation Methods for treatment of pain
CN101820755B (zh) 2007-08-10 2013-05-15 巴赛尔·雷盖斯 抗炎化合物及其应用
WO2013130625A1 (en) * 2012-02-27 2013-09-06 Basil Rigas Phospho-ester derivatives and uses thereof
CN105658651A (zh) * 2012-09-21 2016-06-08 巴兹尔·里格斯 用于治疗炎症相关的病症、疼痛和发热、皮肤病症、癌症及其癌症前期状况的组合物
CA3045004A1 (en) * 2015-12-16 2017-06-22 Achelios Therapeutics, Inc. Methods and compositions for treating peripheral neuropathy
BR112019006160A2 (pt) * 2016-09-28 2019-06-18 Medicon Pharmaceuticals Inc composições e métodos para o tratamento das condições oftálmicas
JP2020536067A (ja) 2017-09-28 2020-12-10 メディコン ファーマシューティカルズ,インコーポレイテッド 眼の状態を処置するための組成物および方法

Also Published As

Publication number Publication date
FI4114403T3 (fi) 2023-07-27
PT4114403T (pt) 2023-08-17
SI4114403T1 (sl) 2023-10-30
AU2022283458A1 (en) 2024-01-18
CN117377476A (zh) 2024-01-09
BR112023024422A2 (pt) 2024-02-20
MA58889B1 (fr) 2023-06-28
WO2022251805A1 (en) 2022-12-01
KR20240013092A (ko) 2024-01-30
EP4275749A3 (en) 2024-01-03
PL4114403T3 (pl) 2023-10-09
DK4114403T3 (da) 2023-07-24
US20240180936A1 (en) 2024-06-06
EP4275749A2 (en) 2023-11-15
RS64471B1 (sr) 2023-09-29
EP4114403A1 (en) 2023-01-11
JP2024520463A (ja) 2024-05-24
MX2023013855A (es) 2023-12-08
ES2952672T3 (es) 2023-11-03
EP4114403B1 (en) 2023-06-07
HRP20230541T1 (hr) 2023-09-29
LT4114403T (lt) 2023-09-25
CA3220195A1 (en) 2022-12-01

Similar Documents

Publication Publication Date Title
EP3793617A4 (en) TREATMENT OF NEUROPATHIC PAIN ASSOCIATED WITH PERIPHERAL NEUROPATHY INDUCED BY CHEMOTHERAPY
HUE062891T2 (hu) Kemoterápia által indukált perifériás neuropátiával összefüggõ neuropátiás fájdalom kezelése
PT4114404T (pt) Ratamento da dor associada à neuropatia periférica diabética
IL290487A (en) Palm for the treatment of chemotherapy-induced peripheral neuropathy that may occur from cancer treatment
IL282287A (en) Use of a carbamate compound to prevent, alleviate or treat diabetic peripheral neuropathy or peripheral neuropathy caused by chemotherapy
GB202103122D0 (en) Treatment
GB202016058D0 (en) Therapeautic treatment
GB202003722D0 (en) Treatment
GB202002711D0 (en) Treatment
GB202107137D0 (en) Stroke treatment
GB202015386D0 (en) Stroke treatment
IL290403A (en) Prevention and treatment of hypoglycemia
CA205635S (en) Churro twist pet treat
GEP20237524B (en) Pharmaceutical combination comprising trazodone for the treatment of neuropathic pain
GB202016957D0 (en) Beneficial treatment
GB202102488D0 (en) Treatment
GB202102373D0 (en) Treatment
GB202102410D0 (en) Treatment
GB202102369D0 (en) Treatment
GB202102366D0 (en) Treatment
GB202101875D0 (en) Treatment
GB202101213D0 (en) Treatment
GB202101212D0 (en) Treatment
GB202101210D0 (en) Treatment
GB202101211D0 (en) Treatment